Karen DeSalvo - Welltower Independent Director
| WELL Stock | USD 137.88 0.48 0.35% |
Director
Dr. Karen B. DeSalvo is Independent Director of the company. Dr. DeSalvo was a physician and professor of medicine and population health at the University of Texas at Austin Dell Medical School since January 2018. From 2014 to 2017, she served as Acting Assistant Secretary for Health at the U.S. Department of Health and Human Services and as National Coordinator for Health Information Technology. From 2011 to 2014, she served as the Health Commissioner for the City of New Orleans. Dr. DeSalvos experience in medical and public health leadership, health care technology, health care delivery and health care innovation make her an important addition to the Board. since 2018.
| Age | 54 |
| Tenure | 6 years |
| Professional Marks | Ph.D |
| Address | 4500 Dorr Street, Toledo, OH, United States, 43615-4040 |
| Phone | 419 247 2800 |
| Web | https://www.welltower.com |
Karen DeSalvo Latest Insider Activity
Tracking and analyzing the buying and selling activities of Karen DeSalvo against Welltower stock is an integral part of due diligence when investing in Welltower. Karen DeSalvo insider activity provides valuable insight into whether Welltower is net buyers or sellers over its current business cycle. Note, Welltower insiders must abide by specific rules, including filing SEC forms every time they buy or sell Welltower'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Karen DeSalvo over six months ago Acquisition by Karen DeSalvo of tradable shares of Welltower at 92.04 subject to Rule 16b-3 |
Welltower Management Efficiency
The company has return on total asset (ROA) of 0.0185 % which means that it generated a profit of $0.0185 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0342 %, meaning that it created $0.0342 on every $100 dollars invested by stockholders. Welltower's management efficiency ratios could be used to measure how well Welltower manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to 0.01. The value of Return On Capital Employed is expected to slide to 0.03. At this time, Welltower's Other Current Assets are quite stable compared to the past year. Debt To Assets is expected to rise to 0.51 this year, although the value of Net Tangible Assets will most likely fall to about 14.9 B.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Kimberly Ouimet | National Health Investors | N/A | |
| Ronald Marston | Global Medical REIT | 78 | |
| Richard Gilchrist | Ventas Inc | 74 | |
| Peter Lyle | Healthcare Realty Trust | 56 | |
| Roscoe Moore | Global Medical REIT | 76 | |
| Henry Cole | Global Medical REIT | 76 | |
| Huiqi Zhang | Global Medical REIT | 31 | |
| Robert Hensley | Community Healthcare Trust | 63 | |
| Colleen Schaller | National Health Investors | N/A | |
| Roxanne Martino | Ventas Inc | 63 | |
| James Shelton | Ventas Inc | 66 | |
| Robert Adams | National Health Investors | 74 | |
| Nancy Agee | Healthcare Realty Trust | 68 | |
| Christann Vasquez | Healthcare Realty Trust | 60 | |
| Sean Nolan | Ventas Inc | 52 | |
| Robert Reed | Ventas Inc | 68 | |
| Alan Gardner | Community Healthcare Trust | 67 | |
| Matthew Lustig | Ventas Inc | 59 | |
| Edward Braman | Healthcare Realty Trust | 64 | |
| Matthew Cypher | Global Medical REIT | 44 | |
| Bruce Sullivan | Healthcare Realty Trust | 79 | |
Management Performance
| Return On Equity | 0.0342 | ||||
| Return On Asset | 0.0185 |
Welltower Leadership Team
Elected by the shareholders, the Welltower's board of directors comprises two types of representatives: Welltower inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Welltower. The board's role is to monitor Welltower's management team and ensure that shareholders' interests are well served. Welltower's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Welltower's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Matthew McQueen, Executive Vice President, General Counsel, Corporate Secretary | ||
| Jack Rahner, VP Technology | ||
| Justin Skiver, Senior Vice President Global Head of Seniors Housing | ||
| Kenneth Bacon, Non-Executive Chairman of the Board | ||
| Nicholas Rumanes, Vice President - Head of Development | ||
| Sharon Oster, Independent Director | ||
| John Olympitis, Senior Development | ||
| Johnese Spisso, Independent Director | ||
| Ayesha Menon, Senior Vice President - Strategic Investments | ||
| Diana Reid, Independent Director | ||
| Pam Byrne, Senior Capital | ||
| Ryan Rothacker, Vice President - Portfolio Management & Operations | ||
| Joshua Fieweger, Senior Vice President Chief Accounting Officer | ||
| Jeffrey Donahue, Independent Chairman of the Board | ||
| Timothy McHugh, Chief Financial Officer, Executive Vice President | ||
| John Burkart, Chief Operating Officer, Executive Vice President | ||
| Richard Hansen, Vice Management | ||
| Karen DeSalvo, Independent Director | ||
| Matthew JD, General VP | ||
| Kathryn Sullivan, Independent Director | ||
| Nikhil Chaudhri, Executive Officer | ||
| Sergio Rivera, Independent Director | ||
| Joseph Weisenburger, Senior Management | ||
| Mark Hernandez, Chief Officer | ||
| SHANKH MITRA, Chief Executive Officer, Chief Investment Officer, Director | ||
| Mary JD, VP Admin | ||
| Philip Hawkins, Independent Director | ||
| Krishna Soma, Senior Finance | ||
| Timothy CFA, Executive CFO |
Welltower Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Welltower a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0342 | ||||
| Return On Asset | 0.0185 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 98.15 B | ||||
| Shares Outstanding | 622.69 M | ||||
| Shares Owned By Insiders | 0.09 % | ||||
| Shares Owned By Institutions | 98.74 % | ||||
| Number Of Shares Shorted | 9.67 M | ||||
| Price To Earning | 142.06 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Welltower. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Welltower Stock please use our How to buy in Welltower Stock guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Welltower. If investors know Welltower will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Welltower listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.004 | Dividend Share 2.56 | Earnings Share 1.57 | Revenue Per Share 12.941 | Quarterly Revenue Growth 0.288 |
The market value of Welltower is measured differently than its book value, which is the value of Welltower that is recorded on the company's balance sheet. Investors also form their own opinion of Welltower's value that differs from its market value or its book value, called intrinsic value, which is Welltower's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Welltower's market value can be influenced by many factors that don't directly affect Welltower's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Welltower's value and its price as these two are different measures arrived at by different means. Investors typically determine if Welltower is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Welltower's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.